title: Chronic necrotizing pulmonary aspergillosis in pneumoconiosis: clinical and radiologic findings in 10 patients.
abstract: OBJECTIVE
  To characterize clinical, radiographic, and CT findings of chronic necrotizing pulmonary aspergillosis (CNPA) in patients with pneumoconiosis.
  
  
  METHODS
  We studied 10 patients with pneumoconiosis who were seen at Asahi Rosai Hospital and received a clinical diagnosis of CNPA during a 15-year period, and detailed the long-term clinical and radiologic courses of four cases.
  
  
  RESULTS
  All patients were men, ranging in age from 48 to 77 years (mean, 60.1 years). Their occupational histories included pottery making (n = 9) and coal mining (n = 1). Chest radiographic findings by the International Labor Organization profusion grading system were greater than category 2. All patients were symptomatic, with a productive cough, hemoptysis, and dyspnea. Serum findings were positive for the Aspergillus antibody in seven patients. The radiologic findings consisted of parenchymal infiltrates and cavities mostly containing mycetoma, which generally involved the upper lobes. The disease progressed slowly; in one patient, broad destruction of the lung was observed after > 10 years without antifungal administration. Most of the patients experienced clinical and radiologic improvement after receiving antifungal therapy, by oral, inhaled, or intracavitary administration.
  
  
  CONCLUSIONS
  Chronic persistent or progressive upper-lobe infiltrates and cavities in patients with pneumoconiosis should raise the possibility of CNPA. Early diagnosis and initiation of effective therapy are recommended to achieve a better outcome.
authors.affiliation: Department of Internal Medicine, Asahi Rosai Hospital, Aichi, Japan. takakato@sunprom.med.nagoya-cu.ac.jp
authors.forename: Takashi
authors.initials: T
authors.lastname: Kato
authors.forename: Ikuji
authors.initials: I
authors.lastname: Usami
authors.forename: Hiroki
authors.initials: H
authors.lastname: Morita
authors.forename: Masahiro
authors.initials: M
authors.lastname: Goto
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Hosoda
authors.forename: Atsushi
authors.initials: A
authors.lastname: Nakamura
authors.forename: Shogo
authors.initials: S
authors.lastname: Shima
mesh_terms: D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000000981:diagnostic imaging* / Q000188:drug therapy; D002908:Chronic Disease; D005500:Follow-Up Studies; D006801:Humans; D008172:Lung Diseases, Fungal / Q000000981:diagnostic imaging* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D008271:Mycetoma / Q000000981:diagnostic imaging / Q000188:drug therapy; D009336:Necrosis; D011009:Pneumoconiosis / Q000000981:diagnostic imaging*; D012307:Risk Factors; D014057:Tomography, X-Ray Computed
chemical_list: D000935:Antifungal Agents